in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Private equity firm acquires Micron Technologies
9:43 PM MDT | March 25, 2013 | Deepti Ramesh
Private equity firm Arlington Capital Partners (Washington) says it has acquired Micron Technologies (Malvern, PA), a global provider of particle size engineering and related analytical services to the pharmaceutical industry. Financial details were not disclosed. Micron focuses on solving the pharmaceutical industry’s most difficult bio-availability and drug delivery challenges through multiple particle size reduction technologies, Arlington says. Micron is the leading independent provider of micronization services for solubility enhancement of active...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee